These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2484293)

  • 41. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
    Brosteanu O; Hasenclever D; Loeffler M; Diehl V;
    Ann Hematol; 2004 Mar; 83(3):176-82. PubMed ID: 15064867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
    Castelo-Branco C; Nomdedeu B; Camus A; Mercadal S; Martínez de Osaba MJ; Balasch J
    Fertil Steril; 2007 Mar; 87(3):702-5. PubMed ID: 17173900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J
    Rev Clin Esp; 1987 Feb; 180(3):158-64. PubMed ID: 2437622
    [No Abstract]   [Full Text] [Related]  

  • 45. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 46. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
    Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
    Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hodgkin disease and amyloidosis].
    Jekunen A; Maiche A; Laurila P; Franssila K; Elomaa I
    Duodecim; 1994; 110(6):602-6. PubMed ID: 7555860
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 50. [Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
    Gabryś K; Kotlarek-Haus S; Sciborski R
    Pol Tyg Lek; 1986 Feb; 41(7):195-8. PubMed ID: 2423994
    [No Abstract]   [Full Text] [Related]  

  • 51. [Radiotherapy of Hodgkin's disease].
    Patrício MB
    Acta Med Port; 1990; 3(1):11-3. PubMed ID: 1692179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of the treatment of lymphogranulomatosis].
    Kholin AV
    Ter Arkh; 1986; 58(2):143-7. PubMed ID: 2422774
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
    Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():33-9. PubMed ID: 15688474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
    Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
    Ansell SM
    Am J Hematol; 2016 Jan; 91(1):109-12. PubMed ID: 26505486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Chemotherapy of malignant lymphomas].
    Luporini G
    Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
    Robert M; Averous M; Lavabre-Bertrand T; Iborra F; Chevallier P; Rebillard X; Guiter J; Grasset D
    J Urol (Paris); 1992; 98(3):178-80. PubMed ID: 1282922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follow-up of sperm concentration and motility in patients with lymphoma.
    Tal R; Botchan A; Hauser R; Yogev L; Paz G; Yavetz H
    Hum Reprod; 2000 Sep; 15(9):1985-8. PubMed ID: 10967000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    Carde P; Cavalli F; Diehl V; Franklin J
    Hematol J; 2000; 1(4):282-90. PubMed ID: 11920203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.